close

PHD VACANCY HTA in (de)-escalation of treatment in HER2+ breast cancer

Updated: 17 Nov 2024

link
provider logo
Research / Academic
Rotterdam

The research group of Prof.dr. C. Uyl-de Groot and V.P. Retèl conduct Health Technology Assessment (HTA) and health economic research alongside the translational pathway and aim to contribute to accelerate patient access in case of promising innovations. Health economic studies and HTA have become increasing important from early stages of research that lead to clinical innovations. They help to inform policy- and reimbursement decisions, to guide the translational research process, and to anticipate on technological and environmental developments.

The Project
HER2+ breast cancer affects around 390.000 women annually worldwide (i.e. 3 patients every 4 minutes). Over the last decade, polychemotherapy and HER2-targeted therapies have improved patient´s survival; however, the reality is that most patients could be cured with less intense, toxic, and costly drugs. The DEFINITIVE project is an European-wide, multidisciplinary project which will prospectively validate the clinical effectiveness of a new biomarker, proving its ability to significantly i) reduce toxicities, ii) improve quality of life and ii) reduce direct and indirect costs, while maintaining efficacy endpoints and survival outcomes in patients with early HER2+ breast cancer.

The ESHPM of the Erasmus University Rotterdam is responsible for the work package (WP) concerning Health Technology Assessment (including health economic, patient-related, organizational and ELSI aspects). A multi-center, international cost-effectiveness analysis will be performed, including implementation scenarios with relevant stakeholders.

Requirements:

We seek a highly motivated and ambitious PhD student with a strong affinity for health economics, healthcare policy and computational science.

PhD specific job requirements

We are searching for a researcher with the following expertise and experience:

  • You have a Master degree in Health Sciences OR Health Economics OR Epidemiology OR Computational Science OR Econometrics OR related degree
  • You are interested in applied decision modelling in the field of health care (our connection with the clinic is very strong);
  • Strong communication skills, both written and verbal (English). Dutch language skills are not required, but could be handy.

Salary Benefits:

We offer you an internationally oriented and varied job in an enthusiastic team, with excellent working conditions in accordance with the Collective Labour Agreement for Dutch Universities (CAO-NU).

The start date of this position is 01-FEB-2025 and you will be based at [class.26087] in Erasmus School of Health Policy & Management (ESHPM). This position is for 1 fte. We offer a 1,5-year position which will be extended to 4 years based on performance. The salary ranges from a minimum of € 2.872 to a maximum of € 3.670 gross per month Scale PhD on a fulltime basis (38 hours), in accordance with the CAO-NU.

Everything else we offer you, you can find below!

Work Hours:

40 hours per week

Address:

Burgemeester Oudlaan 50